These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6128663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ, Grider JR, Gardiner J, Vlahcevic ZR.
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vagal inhibition of gastric acid secretion: evidence for cholecystokinin as the inhibitory transmitter in the mouse stomach.
    Davison JS, Najafi-Farashah A.
    Can J Physiol Pharmacol; 1987 Sep; 65(9):1937-41. PubMed ID: 2891425
    [Abstract] [Full Text] [Related]

  • 7. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
    Nishida A, Yuki H, Tsutsumi R, Miyata K, Kamato T, Ito H, Yamano M, Honda K.
    Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y.
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [Abstract] [Full Text] [Related]

  • 9. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity.
    Miller LJ, Reilly WM, Rosenzweig SA, Jamieson JD, Go VL.
    Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926
    [Abstract] [Full Text] [Related]

  • 10. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach.
    El Munshid HA, Håkanson R, Liedberg G, Sundler F.
    J Physiol; 1980 Aug; 305():249-65. PubMed ID: 6108365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stimulatory effect of dibutyryl cyclic GMP on acid secretion in mouse isolated stomach and on histamine release in gastric mucosal cells.
    Horie S, Hasebe K, Koshikawa H, Tsuchiya S, Yano S, Watanabe K.
    J Physiol Paris; 2000 Aug; 94(1):25-9. PubMed ID: 10761685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dibutyryl cGMP: inhibitor of the effect of cholecystokinin and gastrin on the guinea pig gallbladder in vitro.
    Poitras P, Iacino D, Walsh JH.
    Biochem Biophys Res Commun; 1980 Sep 16; 96(1):476-82. PubMed ID: 6254515
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.